Stay updated on CTL019 in Adult ALL: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page.

Latest updates to the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding notice warning about potential delays and outdated information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check42 days agoChange DetectedScreenshot shows minor formatting cleanups and wording adjustments on the study details page, with no changes to core content such as eligibility criteria, primary outcomes, locations, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.SummaryDifference4%

- Check78 days agoChange DetectedContent shifts to focus on Lymphoma and related virus infections, replacing broader leukemia and hematologic disease terms and updating the revision to v3.1.0.SummaryDifference2%

- Check92 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.2%

Stay in the know with updates to CTL019 in Adult ALL: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page.